The $540M Signal: How a Tiny Biotech Exposed Wall Street’s Real Crypto Plan
Échec de l'ajout au panier.
Échec de l'ajout à la liste d'envies.
Échec de la suppression de la liste d’envies.
Échec du suivi du balado
Ne plus suivre le balado a échoué
The $540M Signal: How a Tiny Biotech Exposed Wall Street’s Real Crypto Plan
-
Narrateur(s):
-
Auteur(s):
À propos de cet audio
Front Run The Week — Free Signals
Get early signals before they hit headlines. Subscribe free — or upgrade for member rewards — at https://tokentrust.substack.com
A tiny biotech nobody was watching just raised $540 million — not for FDA trials, not for M&A, but to build a Digital Asset Treasury and Super Validator operation tied to the institutional blockchain backed by Goldman, Citadel Securities, BNP Paribas, and Circle.
In this episode, Chip Mahoney breaks down why this move matters, how Wall Street is positioning itself behind the scenes, and why this moment may be bigger than the ETF wave. This is where the real rails are being built — and where the real money is going.
Want to go deeper?
Start here: Own The Economy — my framework for tracking the Digital Dollar shift, early Signals, and the infrastructure institutions are quietly building.
🔶https://tokentrust.substack.com/p/start-here-own-the-economy
Paid members unlock Signals, weekly intelligence, and early access.
There’s also a 7-day free trial if you want to explore first.
The Chip Mahoney Show delivers financial intelligence for the Digital Dollar era — helping investors and advisors stay early, not reactive.
More at chipmahoney.com
Media & partnerships: dvpodcastshow@gmail.com
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.